Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.



  • In Brief for April 27, 2022

    In Brief for April 27, 2022

    By

    Erin Jungmeyer
    Names & News

    Dr. Jhanelle Gray takes the reins as chair of the SWOG Lung Cancer Committee. Keep reading for more about this and other moves in thoracic oncology.


  • In Brief for February 9, 2022

    In Brief for February 9, 2022

    By

    John Austin
    Evolving Standards of Care, Meeting News, Names & News

    TTLC goes virtual. Positive results reported for pembrolizumab. GO2 Foundation names Chief of Healthcare Delivery.


  • Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March

    Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March

    By

    Erin Jungmeyer
    Names & News, Society News

    Longtime member Karen Kelly, MD, is set to become the new chief executive officer of the International Association for the Study of Lung Cancer. This March, Dr. Kelly, an internationally renowned lung cancer researcher, will begin collaborating closely with the IASLC Board of Directors and staff to achieve the goals and fulfill the mission established…


  • Ticiana Leal, MD, Moves to Emory University School of Medicine

    Ticiana Leal, MD, Moves to Emory University School of Medicine

    By

    Names & News

    Ticiana Leal, MD, has moved to Emory University School of Medicine as associate professor and director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology. Dr. Leal’s clinical research focuses on clinical trials of chemotherapy and/or immunotherapy agents to treat cancers of the lung. Dr. Leal has authored or coauthored…


  • Prof. Fabrice Barlesi Appointed Chief Executive Officer of Gustave Roussy for a Term of 5 years

    Prof. Fabrice Barlesi Appointed Chief Executive Officer of Gustave Roussy for a Term of 5 years

    By

    Names & News

    Prof. Fabrice Barlesi has been appointed as chief executive officer of Gustave Roussy for a term of 5 years. Prof. Barlesi has been medical director and clinical research director there since January of 2020. Prior to that Prof. Barlesi was professor of medicine at the University of Aix-Marseille and was the head of the Multidisciplinary…


  • David R. Gandara, MD, Appointed Chief Medical Officer (CMO) of the International Society for Liquid
            Biopsy (ISLB)

    David R. Gandara, MD, Appointed Chief Medical Officer (CMO) of the International Society for Liquid Biopsy (ISLB)

    By

    Names & News

    David R. Gandara, MD, has been appointed chief medical officer (CMO) of the International Society for liquid biopsy (ISLB), an international nonprofit organization dedicated to advancing the field of liquid biopsy in cancer diagnosis and management. In addition to being a previous IASLC President (2009-2011), Treasurer (2017), and World Conference President (2009), Dr. Gandara is…


  • Narjust Duma Moves to Dana-Farber Cancer Institute

    Narjust Duma Moves to Dana-Farber Cancer Institute

    By

    Names & News

    Narjust Duma, MD, has been named associate director of the Cancer Care Equity Program and assistant professor of medicine at Dana-Farber Cancer Institute/Harvard Medical School. She will develop strategies to diminish health care disparities and enhance cancer care delivery while continuing her practice as a thoracic oncologist as well as her research, both of which…


  • Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic

    Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic

    By

    Names & News

    Peter Bach, MD, is the new chief medical officer at Delfi Diagnostics, a developer of blood tests for early detection of multiple types of cancer. Dr. Bach leaves Memorial Sloan Kettering after 23 years, where he served as director of the Center for Health Policy and Outcomes. “Lung cancer screening is the ideal place to…


  • Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson

    Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson

    By

    Names & News

    Joshua Bauml, MD, has moved to The Janssen Pharmaceutical Companies of Johnson & Johnson from the University of Pennsylvania. Dr. Bauml was with the University of Pennsylvania for a decade—2 years as a fellow and 8 years as faculty—most recently servicing as an Assistant Professor of Medicine. Dr. Bauml will be joining the lung cancer…


  • Jean-Charles Soria, MD, PhD Joins Amgen

    Jean-Charles Soria, MD, PhD Joins Amgen

    By

    Names & News

    Jean-Charles Soria, MD, PhD, joined Amgen in early August 2021 as senior vice president of the oncology therapeutic sector. Prof. Soria, previously served as senior vice president of Research & Development in Oncology at AstraZeneca, where he was responsible for strategy and development of new immuno-oncology, cell therapy, and conjugated antibody agents. Most recently Dr.…